Targeting RAS�ERK signalling in cancer: promises and challenges. Samatar, A. a. & Poulikakos, P. I. Nature Reviews Drug Discovery, 13(12):928–942, Nature Publishing Group, 2014.
Targeting RAS�ERK signalling in cancer: promises and challenges [link]Paper  doi  bibtex   
@article{Samatar2014,
    author = {Samatar, Ahmed a. and Poulikakos, Poulikos I.},
    doi = {10.1038/nrd4281},
    isbn = {1474-1784 (Electronic)$\backslash$n1474-1776 (Linking)},
    issn = {1474-1776},
    journal = {Nature Reviews Drug Discovery},
    number = {12},
    pages = {928--942},
    pmid = {25435214},
    publisher = {Nature Publishing Group},
    title = {{Targeting RAS�ERK signalling in cancer: promises and challenges}},
    url = {http://www.ncbi.nlm.nih.gov/pubmed/25435214},
    volume = {13},
    year = {2014}
}

Downloads: 0